Raymond James & Associates VALEANT PHARMACEUTICALS INTL Call Options Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Nov 14, 2018
SELL
N/A
-15,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
N/A
-18,000 Reduced 54.55%
15,000 $135,000
Q1 2018

May 14, 2018
BUY
N/A
3,000 Added 10.0%
33,000 $61,000
Q4 2017

Feb 14, 2018
SELL
N/A
-300 Reduced 0.99%
30,000 $131,000
Q3 2017

Nov 13, 2017
BUY
N/A
30,300
30,300 $69,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email